awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q55001442-231600B8-B63C-4E12-8EE4-F3CE53C92B96
Q55001442-231600B8-B63C-4E12-8EE4-F3CE53C92B96
BestRank
Statement
http://www.wikidata.org/entity/statement/Q55001442-231600B8-B63C-4E12-8EE4-F3CE53C92B96
A Phase I Study of ABC294640, a First-in-Class Sphingosine Kinase-2 Inhibitor, in Patients with Advanced Solid Tumors.
P2860
Q55001442-231600B8-B63C-4E12-8EE4-F3CE53C92B96
BestRank
Statement
http://www.wikidata.org/entity/statement/Q55001442-231600B8-B63C-4E12-8EE4-F3CE53C92B96
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
cb87f6635edee46546e81f74fd66b067474a9bfb
P2860
Combined anticancer effects of sphingosine kinase inhibitors and sorafenib.